RVTY
Revvity, Inc.
RVTY's fundamentals are mixed, but it looks expensive: trading at 70x earnings, about twice its usual 38x. Analysts expect earnings growth.
RVTY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Stable |
RVTY's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
RVTY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $40.50 | -74% |
| Forward | 27x | $157 | — |
| Fair | 37x | $84.05 | -46% |
| Expensive | 54x | $121 | -23% |
| Current | 70x | $157 | — |
Historical ranges are pointers, not guarantees.
RVTY's PE is in its expensive range at 70x. If earnings grow as analysts expect, today's price would be 27x next year's earnings, in its fair range.
RVTY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect RVTY's earnings to grow and its profitability to improve, with its revenue holding steady.
RVTY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.81 | +158% |
| Q3 2026 | $2.25 | +14% |
| Q2 2026 | $2.09 | -11% |
| Q1 2026 | $2.08 | -11% |
| Q4 2025 | $2.07 | -5.9% |
| Q3 2025 | $1.98 | -6.6% |
| Q2 2025 | $2.35 | +64% |
| Q1 2025 | $2.34 | +86% |
| Q4 2024 | $2.20 | -60% |
RVTY's earnings per share have fallen from their peak: $2.25 over the past year, against $10.51 in mid-2021.
RVTY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $728.9M | +4.3% |
| Q2 2026 | $729.7M | +1.3% |
| Q1 2026 | $711.1M | +7% |
| Q4 2025 | $772.1M | +5.9% |
| Q3 2025 | $698.9M | +2.2% |
| Q2 2025 | $720.3M | +4.1% |
| Q1 2025 | $664.8M | +2.3% |
| Q4 2024 | $729.4M | +4.8% |
RVTY's revenue has grown year over year for nine quarters in a row: $729M last quarter, up 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +1.3 points |
| Q2 2026 | 12% | -0.4 points |
| Q1 2026 | 11% | -0.2 points |
| Q4 2025 | 14% | -1.8 points |
| Q3 2025 | 12% | -2.6 points |
| Q2 2025 | 13% | +0.2 points |
| Q1 2025 | 11% | +4.1 points |
| Q4 2024 | 16% | +5.2 points |
RVTY's operating margin was 13% last quarter, up 1.3 points from the same quarter a year ago.
RVTY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $152.4M | +27% |
| Q2 2026 | $180.9M | +57% |
| Q1 2026 | $95.5M | -15% |
| Q4 2025 | $161.8M | +8% |
| Q3 2025 | $120M | -4.4% |
| Q2 2025 | $115.5M | -15% |
| Q1 2025 | $112.2M | -14% |
| Q4 2024 | $149.8M | -13% |
RVTY still generates free cash flow, though less than at its 2021 peak: $590M over the past year.
RVTY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +197K shares |
| 1 year | -3.1% | -3.6M shares |
| 3 years | -10% | -12.4M shares |
| 5 years | -2.8% | -3.2M shares |
| Available history | +0.3% | +325K shares |
RVTY has 112M diluted shares, down 3.1% from a year ago, with $271M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $95,000 |
| Q2 2026 | $16M |
| Q1 2026 | $86.5M |
| Q4 2025 | $168.3M |
| Q3 2025 | $205M |
| Q2 2025 | $293.9M |
| Q1 2025 | $153.6M |
| Q4 2024 | $185.2M |
RVTY spent $271M buying back its own shares over the past year, down 68% from the year before.
RVTY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.6x | Moderate |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 3.0x | Elevated |
| Q4 2025 | 3.0x | Elevated |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 2.8x | Moderate |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.6x | Moderate |
RVTY's net debt is about 2.6 years of its operating earnings (EBITDA), down from 3.0 years a year ago.
RVTY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.3 | Overbought |
| Stochastic | 76.5 | Neutral |
RVTY's weekly RSI is 74 (overbought) and its Stochastic is 77 (neutral).
RVTY PE vs Healthcare Sector
| Metric | RVTY | Sector median | Relative |
|---|---|---|---|
| PE | 70x | 26x | 170% above |
| PE % | 91 | 29 | 62 pts above |
RVTY is trading at 70x earnings, a 170% premium to the Healthcare sector's median of 26x.
RVTY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $154.7 | 1.5% above |
| 20 week MA | $134.0 | 17% above |
| 50 week MA | $112.2 | 40% above |
| 100 week MA | $105.9 | 48% above |
| 200 week MA | $110.0 | 43% above |
RVTY has climbed back above all five of its weekly moving averages, and it's now 43% above its 200-week average.
RVTY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $97.1 | $139.7 | +44% |
| 2021 | $139.7 | $193.8 | +39% |
| 2022 | $193.8 | $140.6 | -27% |
| 2023 | $140.6 | $109.3 | -22% |
| 2024 | $109.3 | $112.0 | +2.5% |
| 2025 | $112.0 | $96.8 | -14% |
| 2026 YTD | $96.8 | $157.0 | +62% |
RVTY is up 62% so far in 2026, after finishing lower in three of the previous six years.